PharmacoEconomics & Outcomes News

, Volume 800, Issue 1, pp 28–28 | Cite as

Premenopausal HR+/HER2− mBC has high economic burden

Clinical study


  1. Gauthier G, et al. Economic Burden of HR+/HER2- Metastatic Breast Cancer Among Adult Premenopausal Women. Advances in Therapy : 20 Mar 2018. Available from: URL:

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations